Ipca Laboratories Ltd.

Ipca Laboratories Ltd.

Ipca Laboratories Ltd.

Overview
Date Founded

1949

Headquarters

142-AB, Kandivli Industrial Estate,Kandivili West,Mumbai, Maharashtra 400067

Type of Company

Public

Employees (Worldwide)

19.5K

Industries

Pharmaceuticals

Company Description

Ipca Laboratories Ltd. engages in the manufacture, research, and development of pharmaceutical products. Its products include Hydroxychloroquine Sulphate, Artemether and Lumefantrine and Acceclofenac and its combinations. The company was founded on October 19, 1949 and is headquartered in Mumbai, India.

Website
Contact Data
Trying to get in touch with decision makers at Ipca Laboratories Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
In The News
Executives & Employees

Chief Financial Officer, Executive Director & Joint Managing Director

Executive Director

Executive Director

President-Marketing

President-Global Business

President-Corporate Quality Assurance

Chairman & Managing Director

Corporate Counsel & Company Secretary, Compliance Officer

President-Operations (API)

President-Operations (Formulations)

Board of Directors

Chairman & Managing Director at Ipca Laboratories Ltd.

Executive Director at Ipca Laboratories Ltd.

Executive Director at Ipca Laboratories Ltd.

Chief Financial Officer, Executive Director & Joint Managing Director at Ipca Laboratories Ltd.

Managing Director & Director at Sharda Chem International Pvt Ltd.

Member, Board of Directors at Ipca Laboratories Ltd.

Professor at IIT-Bombay - SJM School of Management

Member, Board of Directors at Ipca Laboratories Ltd.

Paths to Ipca Laboratories Ltd.
Potential Connections via
Relationship Science
You
Ipca Laboratories Ltd.
Owners & Shareholders
Details Hidden

HDFC AMC manages portfolios invested in equity, fixed-income and money-market instruments with a primary focus on Indian securities. They manage a range of investment vehicles including a fixed maturity plan, ETFs, equity and growth funds, debt and income funds, fund of fund schemes, capital protection funds and liquid funds.

Details Hidden

DSP IM is an active, growth-oriented manager which invests in Indian equity and debt across market caps, aiming to achieve consistent, long-term results through a research-based, methodical approach to investing. The investment team concentrates on rigorous fundamental and quantitative management that seeks to achieve the best balance between risk and opportunity. The firm offers a range of fixed-income products for a variety of risk/return profiles. Their equity investment philosophy combines focused portfolio management, proprietary research and significant group resources.

Details Hidden

L&T IM is a conservative, active investor which manages portfolios invested across market caps in equity, fixed-income and money market instruments. They offer a range of diversified and sector specific equity funds, debt funds, asset allocation funds and monthly income funds. Their equity investment strategy follows a bottom-up stock picking approach based on fundamental analysis, tempered by top-down macroeconomic analysis to control risk through diversification. They invest in both value and growth stocks with a medium- to long-term outlook. Their fundamental research process emphasizes an enduring business model, management quality, business fundamentals and valuation.

Recent Transactions
Details Hidden

Ipca Laboratories Ltd., Ipca Pharmaceuticals, Inc. purchase Bayshore Pharmaceutical LLC

Details Hidden

Ipca Laboratories Ltd. purchases Pisgah Labs, Inc.

Details Hidden

Ipca Laboratories Ltd. purchases Krebs Biochemicals & Industries Ltd.

Transaction Advisors
Investment Advisor

Advised onIpca Laboratories Ltd. purchases Krebs Biochemicals & Industries Ltd.

Clients

Makers Laboratories Ltd. engages in manufacturing and marketing of pharmaceutical products. Its products include antibiotic range, cough and cold control, cardio-diabetic, anti-allergic, neurotoxic range, and anthelmintic. The company was founded on July 9, 1984 and is headquartered in Mumbai, India.

May & Baker Nigeria Plc is a pharmaceutical company. It engages in the manufacture, sale, and distribution of pharmaceuticals and consumer products. The firm operates through following segments: Pharmaceuticals and Beverage. The Pharmaceuticals segment involves in the production and sale of human pharmaceuticals and human vaccines. The Beverage segment produces beverage drinks including bottled water. The company was founded by John May, Joseph L. Pickett and Thomas S. in 1834 and is headquartered in Lagos, Nigeria.

Krebs Biochemicals & Industries Ltd. engages in the manufacture and sale of pharmaceutical ingredients and intermediates. Its products include Androstenedione, Lovastatin, and Simvastatin. The company was founded by Ravindranath Tagore Ravi on December 2, 1991 and is headquartered in Hyderabad, India.

Key Stats and Financials As of 2020
Market Capitalization
$3.72B
Total Enterprise Value
$2.33B
Earnings Per Share
$0.63
EBITDAMargin
20.07%
Enterprise Value / Sales
3.86x
Enterprise Value EBITDAOperating
19.24x
TEVNet Income
29.1x
Debt TEV
0.03x
Three Year Compounded Annual Growth Rate Of Revenue
13.77%
Revenue
$604M
Net Profit
$80.1M
EBITDA
$121M
Total Debt
$66.2M
Total Equity
$481M
Suppliers
Ess Dee Aluminium Ltd. Paper Products | Mumbai, India

Ess Dee Aluminium Ltd. is a holding company, which engages in the manufacture of packaging materials for pharmaceutical, food, and fast-moving consumer goods industries. It specializes in cold form blister and child-resistant-blister packaging. The company was founded in 1991 and is headquartered in Mumbai, India.

Outlook Therapeutics, Inc. Pharmaceuticals | South Brunswick, NJ

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification, development, manufacture, and commercialization of ONS-5010/LYTENAVA as the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, including wet AMD, DME and BRVO. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in South Brunswick, NJ.

Borosil Renewables Ltd. Other Raw Materials | Mumbai, India

Borosil Renewables Ltd. engages in the trading and manufacturing of scientific and industrial products, consumer products, and flat glass. It operates through the following segments: Scientificware, Consumerware, Flat Glass, Investments, and Others. The Scientificware segment sells laboratory glassware, scientific ware and pharmacautical packaging. The Consumerware segment manufactures and trades items for domestic use. The Flat Glass segment produces flat glass. The Investments segment involves investment activities. The Other segment comprises of items for industrial use and miscellaneous trading items. The company was founded on December 14, 1962 and is headquartered in Mumbai, India.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ipca Laboratories Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ipca Laboratories Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Ipca Laboratories Ltd..